title: Resolution of Porphyria Cutanea Tarda in Patients With Hepatitis C Following Ledipasvir-Sofosbuvir Combination Therapy.
authors.affiliation: Department of Dermatology, University of California, San Diego2Center For Clinical Studies, Houston, Texas.
authors.forename: Yun
authors.initials: Y
authors.lastname: Tong
authors.affiliation: University of Texas Medical Branch, Galveston.
authors.forename: Ye Kyung
authors.initials: YK
authors.lastname: Song
authors.affiliation: Center For Clinical Studies, Houston, Texas4Department of Dermatology, University of Texas Health Science Center at Houston.
authors.forename: Stephen
authors.initials: S
authors.lastname: Tyring
mesh_terms: D001562:Benzimidazoles / Q000008:administration & dosage*; D001706:Biopsy; D005449:Fluorenes / Q000008:administration & dosage*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017119:Porphyria Cutanea Tarda / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D012867:Skin / Q000473:pathology*; D000069474:Sofosbuvir; D014542:Uridine Monophosphate / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D001562:Benzimidazoles; D005449:Fluorenes; C000595958:ledipasvir, sofosbuvir drug combination; D014542:Uridine Monophosphate; D000069474:Sofosbuvir